have received chemotherapy
The inclusion criterion requires the patient to have chemotherapy-induced amenorrhea or ovarian
have Stage I, II, or III hormone receptor positive breast cancer
taking or planning to take oral estrogen- or progesterone-containing treatments during study participation.
The inclusion criterion requires the patient to have ovarian function
The inclusion criterion requires the patient to have a complete medical history within 60 days
The inclusion criterion requires evidence of serum or plasma estradiol
The inclusion criterion requires the patient to be able to complete Patient-Reported Outcome (PRO)
The inclusion criterion requires the patient to have started initial treatment with standard of care oral
The provided medical history does not contain any information about the patient's
The inclusion criterion requires the patient to have had a menstrual period within the 12 months before
The exclusion criterion specifies that the patient must not have received prior aromatase inhibitor therapy for treatment
The inclusion criterion requires the patient to have completed surgery for treatment of breast cancer at least 14 days
The exclusion criterion specifies that the patient must not start or plan to start tamoxifen during study
The exclusion criterion specifies that the patient should not be receiving additional anti-cancer treatments as part of another clinical trial
The exclusion criterion specifies that the patient must have distant metastatic breast cancer to be excluded
The exclusion criterion specifies that the patient must have a non-breast malignancy for which they are currently receiving treatment